These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 4583148)

  • 1. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection.
    Corry RJ; Winn HJ; Russell PS
    Transplantation; 1973 Oct; 16(4):343-50. PubMed ID: 4583148
    [No Abstract]   [Full Text] [Related]  

  • 2. Active enhancement of donor-strain skin in mice bearing H-2D-incompatible heart allografts.
    Corry RJ; Kelley SE
    Transplant Proc; 1977 Mar; 9(1):945-9. PubMed ID: 325825
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen.
    Steinmuller D; Lofgreen JS
    Nature; 1974 Apr; 248(5451):796-7. PubMed ID: 4599086
    [No Abstract]   [Full Text] [Related]  

  • 4. The H-2 complex: immunogenicity and enhancement studies of H-2K region alloantigens.
    McKenzie IF; Henning MM
    J Immunogenet; 1977 Aug; 4(4):249-57. PubMed ID: 334998
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.
    McKenzie IF; Snell GD
    J Exp Med; 1973 Jul; 138(1):259-77. PubMed ID: 4123828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.
    Jones ND; Turvey SE; Van Maurik A; Hara M; Kingsley CI; Smith CH; Mellor AL; Morris PJ; Wood KJ
    J Immunol; 2001 Feb; 166(4):2824-30. PubMed ID: 11160350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice.
    Stepkowski SM; Raza-Ahmad A; Duncan WR
    Transplantation; 1987 Dec; 44(6):753-9. PubMed ID: 3321584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked prolongation of incompatible class I deficient heart allografts: paradoxical effects between primarily and secondarily vascularized allografts.
    Henretta J; Araneda D; Pittman K; Thomas F
    Transplant Proc; 1995 Feb; 27(1):1303-4. PubMed ID: 7878892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the H-2 genotype in C3HA mice.
    Blandova ZK; Vedernikov AA
    Sov Genet; 1974 Jan; 7(10):1375-7. PubMed ID: 4596370
    [No Abstract]   [Full Text] [Related]  

  • 11. Participation of H-2 regions in heart-transplant rejection.
    Klein J; Chiang C; Lofgreen J; Steinmuller D
    Transplantation; 1976 Oct; 22(4):384-90. PubMed ID: 982543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
    Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of murine cardiac allografts. I. Relative roles of major and minor antigens.
    Burdick JF; Clow LW
    Transplantation; 1986 Jul; 42(1):67-72. PubMed ID: 2941907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection of marrow allografts: importance of H-2 homozygosity of donor cells.
    Bennett M
    Transplantation; 1972 Sep; 14(3):289-98. PubMed ID: 4404692
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of protein restriction on immune response to alloantigens and homograft rejection.
    Nutr Rev; 1976 Aug; 34(8):246-7. PubMed ID: 9603
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the rejection of trunk skin and tail skin allografts involving weak histocompatibility loci.
    Mathieson BJ; Flaherty L; Bennett D; Boyse EA
    Transplantation; 1975 Jun; 19(6):525-7. PubMed ID: 49110
    [No Abstract]   [Full Text] [Related]  

  • 18. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that epidermal alloantigen Epa-1 is an immunogen for murine heart as well as skin allograft rejection.
    Steinmuller D; Wakely E; Landas SK
    Transplantation; 1991 Feb; 51(2):459-63. PubMed ID: 1994543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.